The Development of the Pediatric NAFLD Fibrosis Score (PNFS) to Predict the Presence of Advanced Fibrosis in Children with Nonalcoholic Fatty Liver Disease | PLOS ONE
![Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 - Tokushige - 2021 - Hepatology Research - Wiley Online Library Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 - Tokushige - 2021 - Hepatology Research - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/355d73f6-ab09-4fef-b4e9-0083ef9bb5d3/hepr13688-fig-0001-m.jpg)
Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 - Tokushige - 2021 - Hepatology Research - Wiley Online Library
![Diagnostics | Free Full-Text | Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease Diagnostics | Free Full-Text | Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease](https://www.mdpi.com/diagnostics/diagnostics-11-00098/article_deploy/html/images/diagnostics-11-00098-g001-550.jpg)
Diagnostics | Free Full-Text | Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease
![American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings - Endocrine Practice American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings - Endocrine Practice](https://www.endocrinepractice.org/cms/attachment/a4cfc37a-d93a-456a-8164-d12ac17d79cb/gr2_lrg.jpg)
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings - Endocrine Practice
![Life | Free Full-Text | FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic Life | Free Full-Text | FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic](https://www.mdpi.com/life/life-11-00143/article_deploy/html/images/life-11-00143-g003.png)
Life | Free Full-Text | FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic
![Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches](https://www.mdpi.com/diagnostics/diagnostics-12-00407/article_deploy/html/images/diagnostics-12-00407-g001.png)
Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
![PDF) 40 The Development of the Pediatric NAFLD Fibrosis Score (PNFS) to Predict the Presence of Advanced Fibrosis in Children With Nonalcoholic Fatty Liver Disease PDF) 40 The Development of the Pediatric NAFLD Fibrosis Score (PNFS) to Predict the Presence of Advanced Fibrosis in Children With Nonalcoholic Fatty Liver Disease](https://www.researchgate.net/profile/Daniela-Liccardo/publication/264794632/figure/fig5/AS:341154718601221@1458349031143/Adult-Noninvasive-Fibrosis-Scores-in-Children-with-NAFLD_Q320.jpg)
PDF) 40 The Development of the Pediatric NAFLD Fibrosis Score (PNFS) to Predict the Presence of Advanced Fibrosis in Children With Nonalcoholic Fatty Liver Disease
![Frontiers | Nomogram for Quantitatively Estimating the Risk of Fibrosis Progression in Type 2 Diabetic Patients With Nonalcoholic Fatty Liver Disease: A Pilot Study Frontiers | Nomogram for Quantitatively Estimating the Risk of Fibrosis Progression in Type 2 Diabetic Patients With Nonalcoholic Fatty Liver Disease: A Pilot Study](https://www.frontiersin.org/files/Articles/917304/fendo-13-917304-HTML/image_m/fendo-13-917304-g001.jpg)
Frontiers | Nomogram for Quantitatively Estimating the Risk of Fibrosis Progression in Type 2 Diabetic Patients With Nonalcoholic Fatty Liver Disease: A Pilot Study
![The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-93435-x/MediaObjects/41598_2021_93435_Fig2_HTML.png)